Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (79)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2016 · second_quarter · Pharmacy
HR 800 & S. 806 (Medicare Prompt Pay discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Caner Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Pharmacy
HR 800 & S. 806 (Medicare Prompt Pay discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Caner Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Pharmacy
HR 800 & S. 806 (Medicare Prompt Pay discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Caner Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Pharmacy
HR 800 & S. 806 (Medicare Prompt Pay discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Caner Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Pharmacy
HR 800 & S. 806 (Medicare Prompt Pay discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Caner Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| NC |
| Tom Harkin | Democratic | IA |
2015 · first_quarter · Pharmacy
HR 800 & S. 806 (Medicare Prompt Pay discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Caner Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 4930 - Advancing Care for Exceptional Kids Act of 2014 S. 2461 - The CHIP Extension Act of 2014 H.R. 5364 - The CHIP Extension and Improvement Act of 2014 Issues regarding The Childrens Health Insurance Program (CHIP) H.R. 297/S. 1557 - Acts to reauthorize and establish funding levels for the Children's Hospital Graduate Medical Education program H.R. 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid Issues regarding pediatric quality measures program reauthorization generally (no bill number) S. 2154 - The Emergency Medical Services for Children Reauthorization Act of 2014 H.R. 4290 - The Wakefield Act, reauthorizes Emergency Medical Services for Children S. 2694 - Ensuring Access to Primary Care for Women and Children Act S. 2434 - Family Coverage Act House Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs Senate Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs 340B Drug Discount Program H.R. 225/S.424 - Pediatric Research Network Act H.R. 1698 - Stabilize Medicaid and CHIP Coverage Act S. 689 - Mental Health Awareness and Improvement Act of 2013 H.R. 2607/S. 1251 Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act H.R. 1827 - Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013 S. 957 - Drug Supply Chain Security Act Issues regarding drug compounding and disposal of unused medication Issues regard health information technology
Client expense: $800,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2014 · third_quarter · Health Issues
H.R. 4930 - Advancing Care for Exceptional Kids Act of 2014 S. 2461 - The CHIP Extension Act of 2014 H.R. 5364 - The CHIP Extension and Improvement Act of 2014 Issues regarding The Childrens Health Insurance Program (CHIP) H.R. 297/S. 1557 - Acts to reauthorize and establish funding levels for the Children's Hospital Graduate Medical Education program H.R. 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid Issues regarding pediatric quality measures program reauthorization generally (no bill number) S. 2154 - The Emergency Medical Services for Children Reauthorization Act of 2014 H.R. 4290 - The Wakefield Act, reauthorizes Emergency Medical Services for Children S. 2694 - Ensuring Access to Primary Care for Women and Children Act S. 2434 - Family Coverage Act House Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs Senate Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs 340B Drug Discount Program H.R. 225/S.424 - Pediatric Research Network Act H.R. 1698 - Stabilize Medicaid and CHIP Coverage Act S. 689 - Mental Health Awareness and Improvement Act of 2013 H.R. 2607/S. 1251 Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act H.R. 1827 - Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013 S. 957 - Drug Supply Chain Security Act
Client expense: $800,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2014 · third_quarter · Health Issues
Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; Discussions to clarify or reform the 340B program; Implementation of The Prescription Drug User Fee Act (PDUFA); H.R. 2031, TEST Act
Client expense: $1,520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2014 · fourth_quarter · Health Issues
GPO Safe Harbor; S. 957, the Drug Supply Chain Security Act, H.R. 3204, Drug Quality and Security Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013 S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act H.R. 4437 - Generic Drug Pricing Fairness Act
Client expense: $460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · fourth_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid reimbursement for biotherapeutics, comparative effectiveness research, and FDA approval of follow-on biologics; Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid payment for biotherapeutics, the 340B program, and the Medicare drug benefit; Regulatory and legislative activities regarding 340B program; Issues relating to biologics; S. 959 "Pharmaceutical Compounding Quality and Accounting Act, HR 1416 "Cancer Patient Protection Act of 2013", S.957, "Drug Supply Chain Security", HR 1919 "Safeguarding America's Pharmaceuticals Act"; Issues related to the implementation of the Affordable Care Act of 2010; issues related to biosimilars; Issues concerning clinical trials; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act. Federal Drug. Drug pricing under 340B program; Medical reimbursement - advocacy on behalf of maintaining ASP+6%, 340B Drug Discounting Program - education of Congress on unintended growth of program; Issues related to the implementation of the follow-on biologics provisions in P.L. 111-148 - "Patient Protection and Affordable Care Act"; PHA: Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies.
Client expense: $1,090,200 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
HR 1919 - Safeguarding America's Pharmaceuticals Act of 2013 S. 959 Pharmaceutical Quality, Security, and Accountability Act S. 957 Drug Supply Chain Security Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
H.R.800 & S.806 Medicare Prompt Pay Discount Exclusion (H.R.800 & S.806), legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Cancer Patient Protection Act of 2013 (H.R.1416), legislation to exclude cancer drugs from sequestration cuts. Prescription Drug Abuse Legislation (H.R.1919, H.R.3204, S.957 & S.959)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R. 1919, H.R. 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding. Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
S. 959, "Pharmaceutical Compounding Quality and Accounting Act" H.R. 1416, "Cancer Patient Protection Act of 2013" S. 957, "Drug Supply Chain Security" H.R. 1919, " Safeguarding America's Pharmaceuticals Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
S. 959, "Pharmaceutical Compounding Quality and Accounting Act" H.R. 1416, "Cancer Patient Protection Act of 2013" S. 957, "Drug Supply Chain Security" H.R. 1919, " Safeguarding America's Pharmaceuticals Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
Public Law 112-144 - Implementation Food and Drug Administration Safety and Innovation Act FDASIA H.R. 1919 - Safeguarding Pharmaceuticals Act of 2013 - Track and Trace Pedigree Program S. 957 - Drug Supply Chain Security Act - Track and Trace Pedigree Program H.R. 3204 - Drug Quality & Security Act - Became Public Law 113-54 - Track and Trace Pedigree Program Unique Device Identifiers (UDI) Implementation of UDI Rule 21st Century Cares Initiative - Draft legisation to accelerate the pace of biomedical Innovation and curs by Modernizing Federal Research and Regulatory Agencies
Client expense: $420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
H.R. 4930 - Advancing Care for Exceptional Kids Act of 2014 S. 2461 - The CHIP Extension Act of 2014 H.R. 5364 - The CHIP Extension and Improvement Act of 2014 Issues regarding The Childrens Health Insurance Program (CHIP) H.R. 297/S. 1557 - Acts to reauthorize and establish funding levels for the Children's Hospital Graduate Medical Education program H.R. 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid Issues regarding pediatric quality measures program reauthorization generally (no bill number) S. 2154 - The Emergency Medical Services for Children Reauthorization Act of 2014 H.R. 4290 - The Wakefield Act, reauthorizes Emergency Medical Services for Children S. 2694 - Ensuring Access to Primary Care for Women and Children Act S. 2434 - Family Coverage Act 21st Century Cures Initiative House Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs Senate Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs 340B Drug Discount Program H.R. 225/S.424 - Pediatric Research Network Act H.R. 1698 - Stabilize Medicaid and CHIP Coverage Act H.R. 2607/S. 1251 Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act H.R. 1827 - Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013 S. 957 - Drug Supply Chain Security Act
Client expense: $790,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2014 · fourth_quarter · Health Issues
Pharmaceutical Quality, Security, and Accountability Act S.957
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medical/Disease Research/Clinical Labs
Pharmaceutical Quality, Security, and Accountability Act S.957
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
GPO Safe Harbor; S. 957, the Drug Supply Chain Security Act, H.R. 3204, Drug Quality and Security Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
HR 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Cancer Patient Protection Act of 2013, legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding. Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Insurance
Federal Insurance Office; Implementation of Public Law 112-141 (Flood Insurance Reform and Modernization (Title II) and Student Loan Interest Rate Extension (Title III); Terrorism Risk Insurance Act (TRIA); H.R. 508 (Terrorism Risk Insurance Act of 2002 Reauthorization Act of 2013); H.R. 1945 (Fostering Resilience to Terrorism Act of 2013); H.R. 2146 (S 957 and H.R. 1947 (2013 Farm Bill); S. 534 and H.R.1064 (National Association of Registered Agents and Brokers Reform Act of 2013)
Client expense: $200,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
2014 · third_quarter · Insurance
Federal Insurance Office; Implementation of Public Law 112-141 (Flood Insurance Reform and Modernization (Title II) and Student Loan Interest Rate Extension (Title III); Terrorism Risk Insurance Act (TRIA); H.R. 508 (Terrorism Risk Insurance Act of 2002 Reauthorization Act of 2013); H.R. 1945 (Fostering Resilience to Terrorism Act of 2013); H.R. 2146 (S 957 and H.R. 1947 (2013 Farm Bill); S. 534 and H.R.1064 (National Association of Registered Agents and Brokers Reform Act of 2013)
Client expense: $200,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
2014 · third_quarter · Pharmacy
H.R.800 & S.806 Medicare Prompt Pay Discount Exclusion (H.R.800 & S.806), legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Cancer Patient Protection Act of 2013 (H.R.1416), legislation to exclude cancer drugs from sequestration cuts. Prescription Drug Abuse Legislation (H.R.1919, H.R.3204, S.957 & S.959)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013 S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act H.R. 4437 - Generic Drug Pricing Fairness Act
Client expense: $480,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Health Issues
HR 1919 - Safeguarding America's Pharmaceuticals Act of 2013 S. 959 Pharmaceutical Quality, Security, and Accountability Act S. 957 Drug Supply Chain Security Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
S. 959 "Pharmaceutical Compounding Quality and Accounting Act, HR 1416 "Cancer Patient Protection Act of 2013", S.957, "Drug Supply Chain Security", HR 1919 "Safeguarding America's Pharmaceuticals; Medical Countermeasure Stockpile 340B Drug Discounting Program; FOR - Issues related to the treatment of biologics in international health programs specifically under the Pan American Health Organization
Client expense: $1,079,232 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; Discussions to clarify or reform the 340B program; Implementation of The Prescription Drug User Fee Act (PDUFA); H.R. 2031, TEST Act
Client expense: $1,600,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2014 · third_quarter · Health Issues
H.R. 4930 - Advancing Care for Exceptional Kids Act of 2014 S. 2461 - The CHIP Extension Act of 2014 H.R. 5364 - The CHIP Extension and Improvement Act of 2014 Issues regarding The Childrens Health Insurance Program (CHIP) H.R. 297/S. 1557 - Acts to reauthorize and establish funding levels for the Children's Hospital Graduate Medical Education program H.R. 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid Issues regarding pediatric quality measures program reauthorization generally (no bill number) S. 2154 - The Emergency Medical Services for Children Reauthorization Act of 2014 H.R. 4290 - The Wakefield Act, reauthorizes Emergency Medical Services for Children S. 2694 - Ensuring Access to Primary Care for Women and Children Act S. 2434 - Family Coverage Act House Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs Senate Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs 340B Drug Discount Program H.R. 225/S.424 - Pediatric Research Network Act H.R. 1698 - Stabilize Medicaid and CHIP Coverage Act S. 689 - Mental Health Awareness and Improvement Act of 2013 H.R. 2607/S. 1251 Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act H.R. 1827 - Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013 S. 957 - Drug Supply Chain Security Act
Client expense: $800,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2014 · third_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Public Law 112-144 - Implementation Food and Drug Administration Safety and Innovation Act FDASIA H.R. 1919 - Safeguarding Pharmaceuticals Act of 2013 - Track and Trace Pedigree Program S. 957 - Drug Supply Chain Security Act - Track and Trace Pedigree Program H.R. 3204 - Drug Quality & Security Act - Became Public Law 113-54 - Track and Trace Pedigree Program Unique Device Identifiers (UDI) Implementation of UDI Rule
Client expense: $420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
S.959, "Pharmaceutical Compounding Quality and Accounting Act" H.R. 1416, "Cancer Patient Protection Act of 2013" S.957, "Drug Supply Chain Security" H.R. 1919, "Safeguarding America's Pharmaceuticals Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Medical/Disease Research/Clinical Labs
Pharmaceutical Quality, Security, and Accountability Act S.957
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Pharmaceutical Quality, Security, and Accountability Act S.957
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
GPO Safe Harbor; S. 957, the Drug Supply Chain Security Act, H.R. 3204, Drug Quality and Security Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Pharmacy
H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R. 1919, H.R. 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding. Legislation pertaining to drug manufacturing shortages.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Health care reform implementation; the 340B program of the Health Resources and Services Administration (HRSA), specifically 340B drug pricing program issues, including program expansion and specific issues include: HRSA oversight, definition of patient, the ACAs expansion of covered 340B entitiesOngoing discussions surrounding next steps for protecting and promoting incentives for the development of resistant pathogens including breakpoints Antibiotic resistance among elderly population Reimbursement issues for antibiotics HR 4187, DISARM, Developing Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act H.R. 3742, Antibiotic Development to Advance Patient Treatment (ADAPT) Act
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug;Discussions to clarify or reform the 340B program; Implementation of The Prescription Drug User Fee Act (PDUFA);
Client expense: $880,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2014 · second_quarter · Insurance
Federal Insurance Office; Implementation of Public Law 112-141 (Flood Insurance Reform and Modernization (Title II) and Student Loan Interest Rate Extension (Title III); Terrorism Risk Insurance Act (TRIA); H.R. 508 (Terrorism Risk Insurance Act of 2002 Reauthorization Act of 2013); H.R. 1945 (Fostering Resilience to Terrorism Act of 2013); H.R. 2146 (S 957 and H.R. 1947 (2013 Farm Bill); S. 534 and H.R.1064 (National Association of Registered Agents and Brokers Reform Act of 2013)
Client expense: $150,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
2014 · second_quarter · Health Issues
Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; and community-based public health interventions. 1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148)1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Middle Class Tax Relief and Job Promotion Act (H.R. 3630) 3.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 4.Implementation of Pandemic and All-Hazards Preparedness Act (Public Law 109-417) 5.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 6.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 7.Delivering Antimicrobial Transparency in Animals Act of 2013 (H.R. 820) 8.Animal Drug and Animal Generic Drug User Fee Act (S. 622/H.R.___) 9.Healthier Lifestyles and Prevention America Act (S. 39) 10.Promoting Health as Youth Skills in Classrooms and Life Act (S. 392) 11.Medicare Diabetes Prevention Act (S. 452/H.R. 962) 12.Personal Health Investment Today Act (H.R. 956) 13.A bill to provide for a sequester replacement (S. 16) 14.American Family Economic Protection Act of 2013 (S. 388) 15.Consolidated and Further Continuing Appropriations Act, 2013 (H.R. 933) 16.Regulations From the Executive in Need of Scrutiny Act of 2013 (S. 15 / H.R. 367) 17.To repeal the Prevention and Public Health Fund (H.R. 1099) 18.Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (Public Law 113-5) 19.National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539) 20.Physical Activity Guidelines for Americans Act (S. 531) 21.Firearm Safety and Public Health Research Act (H.R. 321) 22.Helping Sick Americans Now Act (H.R. 1549) 23.Energy Consumers Relief Act (H.R. 1582) 24.Common Sense Nutrition Disclosure Act (H.R. 1249) 25.Improve Nutrition Program Integrity and Deficit Reduction Act (S. 458/H.R. 1510) 26.A bill to amend the Food and Nutrition Act of 2008 to improve the supplemental nutrition assistance program (S. 762/H.R. 1657) 27.Agriculture Reform, Food, and Jobs Act (S. 954/H.R. 2498) 28.Federal Agriculture Reform and Risk Management Act (H.R. 1947) 29.FIT Kids Act (S. 1033/H.R. 2178) 30.Strengthening Americas Schools Act (S. 840) 31.Access to Quality Diabetes Education Act (S. 945/H.R. 1274) 32.Fit to Serve Act (S. 976) 33.Climate Change Health Protection and Promotion Act (H.R. 2023) 34.Treat and Reduce Obesity Act (S. 1184 / H.R. 2415) 35.Student Success Act (H.R. 5) 36.To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act (H.R. 45) 37.Medicare Better Health Rewards Program Act (S. 1228/H.R. 2524) 38.Senate FY14 Labor, Health and Human Services, and Education Bill 39.House of Representatives FY14 Labor, Health and Human Services, and Education Bill 40.Pharmacy Compounding Quality and Accountability Act (S. 959) 41.Safeguarding Americas Pharmaceuticals Act (H.R. 1919) 42.Drug Supply Chain Security Act (S. 957) 43.Preservation of Antibiotics for Medical Treatment Act (H.R. 1150)/Preventing Antibiotic Resistance Act of 2013 (S. 1256) 44.Healthy Families Act (H.R. 1286/S. 631) 45.FY2014 Continuing Resolution (H.J. Res. 59) 46.Drug Quality and Security Act (H.R. 3204) 47.Pharmaceutical Quality, Security and Accountability Act (S. 959) 48.Energy Consumers Relief Act (H.R. 1582) 49.Increasing the Safety of Prescription Drug User Act (not yet introduced proposed by Sen. Udall-NM) 50.National Energy Tax Repeal Act (S. 1324)51.Saving Coal Jobs Act of 2013 (S. 1514) 52.Community Parks Revitalization Act (H.R. 2424) 53.A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings (S. 1422/H.R. 2663) 54.School-based Health Centers Program Reauthorization Act of 2013 (H.R. 2632) 55.Nutrition Reform and Work Opportunity Act (H.R. 3102) 56.Health Equity and Accountability Act (not yet introduced) 57.Secure America for Education (SAFE) in Our Schools Act of 2013 (H.R. 3158) 58.Continuing Appropriations Resolution, 2014 (H.J. Res 59) 59.Continuing Resolution FY 2014 (HR 2775, PL 113-46) 60.A bill to amend title 23, United States Code, with respect to the establishment of performance measures for the highway safety improvement program, and for other purposes. (H.R. 3493/S. 1708) 61.The Farm Bill (S. (S. 954/H.R. 2498; H.R. 1947, and H.R. 3102) 62.Better Care, Lower Cost Act (S. 1932/H.R. 3890) 63.Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) (H.R. 3742) 64.Preventing Antibiotic Resistance Act (S. 1256) 65.The Consolidated Appropriations Act of 2014 66.Strategies to Address Antimicrobial Resistance (STAAR) Act 67.New Opportunities for Bicycling and Pedestrian Infrastructure Financing Act of 2014 (H.R. 3978) 68.Eliminating Disparities in Diabetes Prevention, Access, and Care Act (H.R. 3322) 69.Electricity Security and Affordability Act (HR 3826) 70.Stop Overdose Stat Act (HR 4169) and Senate companion bill soon to be introduced by Senator Reed 71.Opioid Overdose Reduction Act (S. 2092/H.R. 4288) 72.Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 (DISARM Act) (H.R. 4186) 73.Child Care and Development Block Grant Act of 2014 (S. 1086) 74.Departments of Labor, Health and Human Services and Education And Related Agencies Fiscal Year 2015 Appropriations Bill 75.Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 (S. 2389 / H.R. 4800) 76.Department of the Interior, Environment, and Related Agencies appropriations legislation, 2015 77.MAP-21 Reauthorization Act (S. 2322) 78.Stop Subsidizing Childhood Obesity Act (S. 2342/H.R. 2831) 79.ENRICH Act (H.R. 4427) 80.Agricultural Act of 2014 (Public Law 113-79) 81.Healthy Kids Outdoors Act of 2014 (S. 2367/H.R. 4706) 82.A bill to amend the Richard B. Russell National School Lunch Act to improve the efficiency of summer meals (S. 2527) 83.Summer Meals Act of 2014 (HR. 5012) 84.Long-Term SCORE Act (H.R. 4444) 85.American Cures Act (S. 2115/H.R. 4384) 86.A joint resolution to disapprove a rule of the Environmental Protection Agency relating to greenhouse gas emissions from electric utility generating units. (S.J. Res 30) 87.Fit for Life Act of 2014 (H.R.4765) 88.School Food Modernization Act (S. 2210/H.R. 1783) 89.Protecting Children from Electronic Cigarette Advertising Act of 2014 (S. 2014/H.R. 4325) 90.Pedestrian Safety Act of 2014 (S. 2284) 91.Safe Streets Act of 2014 (S. 2004/H.R. 2468) 92.The Recovery Enhancement for Addiction Treatment Act (not yet introduced, by Senator Markey) 93.FY 2015 Financial Services and General Government Appropriations bill, in support of an appropriation for the National Alliance for Model State Drug Laws
Client expense: $38,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
2014 · second_quarter · Health Issues
H.R. 3742, Antibiotic Development to Advance Patient Treatment Act: Provisions related to antibiotics and drug approval H.R. 4069, Ensuring Patient Access and Effective Drug Enforcement Act: Provisions related to the Controlled Substances Act, DEA regulation and related issuesH.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act: Provisions related to the Controlled Substances Act, Drug Enforcement Agency (DEA) regulation and related issues (a reintroduced version of H.R. 4069) S. 264, Excellence in Mental Health Act: Sets forth criteria for the certification of federally-qualified community behavioral health centers S. 957, Drug Supply Chain Security Act: Provisions related to supply chain security S. 959, Pharmaceutical Compounding Quality and Accountability Act: Provisions related to pharmaceutical compounding S. 1723, No ObamaCare Kickbacks Act of 2013: Provisions related to application of the anti-kickback statute to qualified health plans S. 2295, Patient Safety and Generic Labeling Improvement Act: Provisions relating to drug safety labeling (112th Congress) Implementation issues related to the Food and Drug Administration Safety and Innovation Act (Public Law 112-144), including user fee reauthorization and FDA reform Implementation issues related to the Drug Quality and Security Act (Public Law 113-54), including pharmacy compounding and supply chain issues Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including PPACA; Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking Secretary of Health and Human Services nomination Issues related to value and cost of prescription drugs Issues related to user fee reauthorization and FDA reform Patient savings program policy issues Comparative effectiveness policy issues Academic detailing policy issues General HHS, NIH, and FDA related advocacy Biopharmaceutical innovation policy issues Prescription drug abuse policy issues FDA accelerated approval policy issues Unapproved use policy issues 340B policy issues Importation policy issues Clinical trial policy issues
Client expense: $4,190,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · second_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. No. 111-148, Patient Protection and Affordable Care; prescription drug user fee reauthorization issues; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality in Drug Compounding Act of 2013
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Pharmacy
S. 214, Preserve Access to Affordable Generics; implementation of P.L. No. 111-148, Patient Protection and Affordable Care Act; prescription drug user fee reauthorization issues; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
H.R. 4930 - Advancing Care for Exceptional Kids Act of 2014 H.R. 297/S. 1557 - Children's Hospital Graduate Medical Education - acts to reauthorize and establish funding levels for the program H.R. 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid S. 2461 - CHIP Extension Act of 2014, and House companion bill (no bill number) S. 2434 Family Coverage Act House Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs Senate Labor-H Appropriations (no bill number) - provisions impacting Childrens Hospital Graduate Medical Education, NIH and public health programs S. 957 - Drug Supply Chain Security Act Issues related to prescription drug shortages Issues related to prescription drug compounding 340B Drug Discount Program Tax issues related to non-profit hospitals H.R. 225/S.424 - Pediatric Research Network Act H.R. 1698 - Stabilize Medicaid and CHIP Coverage Act S. 689 - Mental Health Awareness and Improvement Act of 2013 H.R. 2019 - Kids First Research Act H.R. 2607/S. 1251 Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act H.R. 1827 - Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013 Pharmacy Compounding S.959/House Companion
Client expense: $1,020,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2014 · second_quarter · Pharmacy
H.R.800 & S.806 Medicare Prompt Pay Discount Exclusion (H.R.800 & S.806), legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Cancer Patient Protection Act of 2013 (H.R.1416), legislation to exclude cancer drugs from sequestration cuts. Prescription Drug Abuse Legislation (H.R.1919, H.R.3204, S.957 & S.959)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
S. 959, "Pharmaceutical Compounding Quality and Accounting Act" H.R. 1416, "Cancer Patient Protection Act of 2013" S. 957, "Drug Supply Chain Security" H.R. 1919, " Safeguarding America's Pharmaceuticals Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE